Clinical analysis of PMS2: Mutation detection and avoidance of pseudogenes

Human Mutation

Volumn 31, Issue 5, 2010, Pages 588-593

  Vaughn, Cecily P ^a   Robles, Jorge ^b   Swensen, Jeffrey J ^a,c   Miller, Christine E ^b   Lyon, Elaine ^a,c   Mao, Rong ^a,c   Bayrak Toydemir, Pinar ^a,c   Samowitz, Wade S ^a,c  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b ARUP LABORATORIES   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Lynch syndrome; PMS2; PMS2CL; Pseudogenes

Indexed keywords

MISMATCH REPAIR PROTEIN PMS2;

ARTICLE; CONTROLLED STUDY; GENE DELETION; GENE LOSS; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOGENE; TUMOR;

ADENOSINE TRIPHOSPHATASES; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MUTATIONAL ANALYSIS; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; GERM-LINE MUTATION; HUMANS; PSEUDOGENES;

EID: 77951826608     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.21230     Document Type: Article

References (24)

1. Auclair J, Leroux D, Desseigne F, Lasset C, Saurin JC, Joly MO, Pinson S, Xu XL, Montmain G, Ruano E, Navarro C. 2007. Novel biallelic mutations in MSH6 and PMS2 genes: gene conversion as a likely cause of PMS2 gene inactivation. Hum Mutat 28:1084-1090. (Pubitemid 350036912)
2. Boland CR. 2005. Evolution of the nomenclature for the hereditary colorectal cancer syndromes. Fam Cancer 4:211-218. (Pubitemid 41242189)
3. Clendenning M, Hampel H, LaJeunesse J, Lindblom A, Lockman J, Nilbert M, Senter L, Sotamaa K, de la Chapelle A. 2006. Long-range PCR facilitates the identification of PMS2-specific mutations. Hum Mutat 27:490-495. (Pubitemid 43673337)
4. Clendenning M, Senter L, Hampel H, Robinson KL, Sun S, Buchanan D, Walsh MD, Nilbert M, Green J, Potter J, Lindblom A. 2008. A frame-shift mutation of PMS2 is a widespread cause of Lynch syndrome. J Med Genet 45:340-345. (Pubitemid 351839474)
5. Cunningham JM, Kim CY, Christensen ER, Tester DJ, Parc Y, Burgart LJ, Halling KC, McDonnell SK, Schaid DJ, Walsh Vockley C, Kubly V. 2001. The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas. Am J Hum Genet 69:780-790.
6. De Vos M, Hayward BE, Picton S, Sheridan E, Bonthron DT. 2004. Novel PMS2 pseudogenes can conceal recessive mutations causing a distinctive childhood cancer syndrome. Am J Hum Genet 74:954-964. (Pubitemid 38568968)
7. Etzler J, Peyrl A, Zatkova A, Schildhaus HU, Ficek A, Merkelbach-Bruse S, Kratz CP, Attarbaschi A, Hainfellner JA, Yao S, Messiaen L. 2008. RNA-based mutation analysis identifies an unusual MSH6 splicing defect and circumvents PMS2 pseudogene interference. Hum Mutat 29:299-305. (Pubitemid 351240603)
8. Gill S, Lindor NM, Burgart LJ, Smalley R, Leontovich O, French AJ, Goldberg RM, Sargent DJ, Jass JR, Hopper JL, Jenkins MA. 2005. Isolated loss of PMS2 expression in colorectal cancers: frequency, patient age, and familial aggregation. Clin Cancer Res 11:6466-6471. (Pubitemid 41338983)
9. Halvarsson B, Lindblom A, Rambech E, Lagerstedt K, Nilbert M. 2006. The added value of PMS2 immunostaining in the diagnosis of hereditary nonpolyposis colorectal cancer. Fam Cancer 5:353-358. (Pubitemid 44924111)
10. Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Clendenning M, Sotamaa K, Prior T, Westman JA, Panescu J. 2008. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol 26:5783-5788.
11. Hayward BE, De Vos M, Valleley EM, Charlton RS, Taylor GR, Sheridan E, Bonthron DT. 2007. Extensive gene conversion at the PMS2 DNA mismatch repair locus. Hum Mutat 28:424-430. (Pubitemid 46668600)
12. Kruger S, Kinzel M, Walldorf C, Gottschling S, Bier A, Tinschert S, von Stackelberg A, Henn W, Gorgens H, Boue S, Kölble K. 2008. Homozygous PMS2 germline mutations in two families with early-onset haematological malignancy, brain tumours, HNPCC-associated tumours, and signs of neurofibromatosis type 1. Eur J Hum Genet 16:62-72. (Pubitemid 350269240)
13. Lynch HT, de la Chapelle A. 2003. Hereditary colorectal cancer. N Engl J Med 348:919-932.
14. Lynch HT, Lynch PM, Lanspa SJ, Snyder CL, Lynch JF, Boland CR. 2009. Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin Genet 76:1-18.
15. Nakagawa H, Lockman JC, Frankel WL, Hampel H, Steenblock K, Burgart LJ, Thibodeau SN, de la Chapelle A. 2004. Mismatch repair gene PMS2: disease-causing germline mutations are frequent in patients whose tumors stain negative for PMS2 protein, but paralogous genes obscure mutation detection and interpretation. Cancer Res 64:4721-4727. (Pubitemid 38924513)
16. Nicolaides NC, Carter KC, Shell BK, Papadopoulos N, Vogelstein B, Kinzler KW. 1995. Genomic organization of the human PMS2 gene family. Genomics 30:195-206.
17. Niessen RC, Kleibeuker JH, Jager PO, Sijmons RH, Hofstra RM. 2007. Getting rid of the PMS2 pseudogenes: mission impossible?. Hum Mutat 28:414; author reply 415.
18. Niessen RC, Kleibeuker JH, Westers H, Jager PO, Rozeveld D, Bos KK, Boersma-van Ek W, Hollema H, Sijmons RH, Hofstra RM. 2009. PMS2 involvement in patients suspected of Lynch syndrome. Genes Chromosomes Cancer 48:322-329.
19. Senter L, Clendenning M, Sotamaa K, Hampel H, Green J, Potter JD, Lindblom A, Lagerstedt K, Thibodeau SN, Lindor NM, Young J. 2008. The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology 135:419-428.
20. Shia J. 2008. Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry. J Mol Diagn 10:293-300. (Pubitemid 352019113)
21. Truninger K, Menigatti M, Luz J, Russell A, Haider R, Gebbers JO, Bannwart F, Yurtsever H, Neuweiler J, Riehle HM, Cattaruzza MS. 2005. Immunohistochemical analysis reveals high frequency of PMS2 defects in colorectal cancer. Gastroenterology 128:1160-1171.
22. van der Klift H, Wijnen J, Wagner A, Verkuilen P, Tops C, Otway R, Kohonen-Corish M, Vasen H, Oliani C, Barana D, Moller P. 2005. Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC). Genes Chromosomes Cancer 44:123-138.
23. Vaughn CP, Lyon E, Samowitz WS. 2008. Confirmation of single exon deletions in MLH1 and MSH2 using quantitative polymerase chain reaction. J Mol Diagn 10:355-360.
24. Zhao YS, Hu FL, Wang F, Han B, Li DD, Li XW, Zhu S. 2009. Meta-analysis of MSH6 gene mutation frequency in colorectal and endometrial cancers. J Toxicol Environ Health A 72:690-697.